Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 May;8(5):267-73.
doi: 10.1038/nrurol.2011.40. Epub 2011 Apr 5.

Inguinal hernia after radical retropubic prostatectomy: risk factors and prevention

Affiliations
Review

Inguinal hernia after radical retropubic prostatectomy: risk factors and prevention

Johan Stranne et al. Nat Rev Urol. 2011 May.

Abstract

The two most frequently occurring and well-described complications of radical retropubic prostatectomy (RRP) for prostate cancer are incontinence and impotence. Inguinal hernia (IH) has, over the last decade, emerged as an additional complication, with an estimated incidence of 15-20% after RRP. IH is a common lesion in men aged between 50 and 70 years with or without prostate cancer, and the literature indicates that annual incidence is somewhere between 0.5% and 1% in the general male population. Important risk factors for the development of post-RRP IH are previous IH surgery, increasing age, and low BMI. However, subclinical IH at the time of RRP and a lower midline incision seem to be the most important causative factors. Prophylactic procedures and, in the case of clinically detectable IH lesions, concurrent repair during RRP are advocated. Reports on alternative approaches to RRP, such as minilaparotomy RRP, laparoscopic radical prostatectomy (including robot-assisted procedures) and radical perineal prostatectomy have indicated low rates of postoperative IH. The risk of developing IH after prostatectomy should be part of the preoperative risk assessment when making treatment decisions for patients with prostate cancer.

PubMed Disclaimer

Similar articles

Cited by

References

    1. BJU Int. 2010 Nov;106(10):1468-72 - PubMed
    1. Urology. 2004 Feb;63(2):278-81 - PubMed
    1. J Urol. 1999 Mar;161(3):840-3 - PubMed
    1. J Urol. 1998 Dec;160(6 Pt 2):2418-24 - PubMed
    1. J Urol. 2010 Sep;184(3):984-9 - PubMed

MeSH terms

LinkOut - more resources